Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Diane Niño"'
Autor:
Luis M Franco, Kristine L Bucasas, Janet M Wells, Diane Niño, Xueqing Wang, Gladys E Zapata, Nancy Arden, Alexander Renwick, Peng Yu, John M Quarles, Molly S Bray, Robert B Couch, John W Belmont, Chad A Shaw
Publikováno v:
eLife, Vol 5 (2016)
Externí odkaz:
https://doaj.org/article/6a07de74f997448ab1ed841bf2c447c6
Autor:
Yijie Zhai, Luis M Franco, Robert L Atmar, John M Quarles, Nancy Arden, Kristine L Bucasas, Janet M Wells, Diane Niño, Xueqing Wang, Gladys E Zapata, Chad A Shaw, John W Belmont, Robert B Couch
Publikováno v:
PLoS Pathogens, Vol 11, Iss 6, p e1004869 (2015)
To better understand the systemic response to naturally acquired acute respiratory viral infections, we prospectively enrolled 1610 healthy adults in 2009 and 2010. Of these, 142 subjects were followed for detailed evaluation of acute viral respirato
Externí odkaz:
https://doaj.org/article/968df99b117146e3ad23b488dafbb098
Autor:
Luis M Franco, Kristine L Bucasas, Janet M Wells, Diane Niño, Xueqing Wang, Gladys E Zapata, Nancy Arden, Alexander Renwick, Peng Yu, John M Quarles, Molly S Bray, Robert B Couch, John W Belmont, Chad A Shaw
Publikováno v:
eLife, Vol 2 (2013)
Identification of the host genetic factors that contribute to variation in vaccine responsiveness may uncover important mechanisms affecting vaccine efficacy. We carried out an integrative, longitudinal study combining genetic, transcriptional, and i
Externí odkaz:
https://doaj.org/article/0ed553e2c2da41cb90e5b8d8ccd3d7c0
Autor:
Robert B Couch, William K Decker, Budi Utama, Robert L Atmar, Diane Niño, Jing Qi Feng, Matthew M Halpert, Gillian M Air
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50830 (2012)
BackgroundSerum antibody responses in humans to inactivated influenza A (H5N1), (H9N2) and A (H7) vaccines have been varied but frequently low, particularly for subunit vaccines without adjuvant despite hemagglutinin (HA) concentrations expected to i
Externí odkaz:
https://doaj.org/article/b2c6552a2ae74c4d8139020b989b6f42
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e49704 (2012)
Concern for a pandemic caused by a newly emerged avian influenza A virus has led to clinical trials with candidate vaccines as preparation for such an event. Most trials have involved vaccines for influenza A (H5N1), A (H7N7) or A (H9N2).To evaluate
Externí odkaz:
https://doaj.org/article/46b6c432cc9340afa7d1ed84537fd8b4
Autor:
Janet M. Wells, Nancy Arden, Chad A. Shaw, John W. Belmont, Kristine L. Bucasas, Luis M. Franco, John M. Quarles, Peng Yu, Molly S. Bray, Xueqing Wang, Alexander Renwick, Robert B. Couch, Diane Niño, Gladys Zapata
Publikováno v:
eLife, Vol 5 (2016)
Autor:
Janet M. Wells, Robert B. Couch, John M. Quarles, Robert L. Atmar, Shital M. Patel, Heather Hill, Thomas R. Cate, Kuo Guo, Nancy Arden, Diane Niño, Wendy A. Keitel
Publikováno v:
Vaccine. 29:8066-8072
Avian influenza A/H9N2 viruses can infect people and are viruses considered to be a potential pandemic threat. Prior studies with an inactivated G1 clade H9N2 vaccine reported that persons born before 1968 were more likely to have an immune response
Autor:
Luis M. Franco, Chad A. Shaw, Janet M. Wells, Molly S. Bray, Robert B. Couch, Diane Niño, John W. Belmont, Kristine L. Bucasas, John M. Quarles, Nancy Arden
Publikováno v:
The Journal of Infectious Diseases. 203:921-929
Background. Annual vaccination is the primary means for preventing influenza. However, great interindividual variability exists in vaccine responses, the cellular events that take place in vivo after vaccination are poorly understood, and appropriate
Autor:
Robert B. Couch, Patricia L. Winokur, Wilbur H. Chen, Thomas R. Cate, Rebecca C. Brady, Robert B. Belshe, Robert L. Atmar, Diane Niño, Rayford Y
Publikováno v:
Vaccine. 28:2076-2079
Antibody to the neuraminidase (NA) antigen of influenza viruses has been shown to correlate with immunity to influenza in humans and animal models. In a previous report, we showed that an inactivated influenza vaccine containing 60microg of the hemag
Autor:
Robert R. Edelman, Jose Capellan, Thomas R. Cate, Bryndis Sigurdardottir, Robert B. Belshe, Fenhua He, Wilbur H. Chen, Robert B. Couch, Patricia L. Winokur, Rebecca C. Brady, Amy Hoeper, Frederick L. Ruben, Diane Niño, Irene Graham
Publikováno v:
Vaccine, 25(44), 7656-7663. ELSEVIER SCI LTD
To improve immune responses to influenza vaccine, a trivalent inactivated vaccine containing 60 mu g of the HA of each component (A/H3N2, A/H1N1, B) was compared to a licensed vaccine containing 15 mu g of the HA of each. More local and systemic reac